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Aim. To discover the mechanisms of the PPM1M and PRICKLE2 genes expression alterations in clear 
cell renal cell carcinomas. Methods. Study of the copy number was performed, using the quantitative 
PCR (Q-PCR). Results. Deletions of PPM1M were found in 55 % of cases, amplifi cations – in 17 % and 
in 28 % of samples there were no changes of the copy number. We found the deletions of PRICKLE2 in 
50 % of samples, no changes of the copy number in 39 %, and amplifi cations in 11 % of cases. Conclu-
sions. By the analysis of the gene copy number we have shown that homo- and heterozygous deletions 
are the main reason of changes in expression of the PPM1M and PRICKLE2 genes.
K e y w o r d s: clear cell renal cell carcinoma, heterozygous deletions, quantitative PCR, copy number 
analysis.
Introduction
Annual incidence of tumors of the genitourinary sys-
tem is over 200 thousand worldwide. During 2011 the 
kidney cancer was diagnosed in 5622 patients in 
Ukraine; 2469 of them died. For a quarter of these pa-
tients a period from the time of diagnosis to death is 
very short, less than one year (see http://www.ncru.inf.
ua/publications/BULL_14/PDF_E/49-50- poch.pdf). 
Among urologic tumors, clear cell renal cell carcinoma 
(ccRCC later on in the text) takes the third place in in-
cidence, following prostate and bladder cancer. ccRCC 
is the fi rst by the number of death. ccRCC is the preva-
lent malignancy of the kidney, accounting for about 85 
% of kidney cancers [1]. Kidney carcinoma is associ-
ated with the most negative prognosis and responds 
poorly to medical treatment, as a rule [2]. The course of 
disease and treatment depends on the molecular profi le 
of tumors. Very important is to study the expression 
pattern of tumor suppressor genes (TSG) that play an 
important role in cancerogenesis. The TSG expression 
is usually downregulated in tumors by different mecha-
nisms, such as genetic and epigenetic alterations. One 
of the most frequent aberrations in solid tumors is inac-
tivation of TSG in chromosome 3 [3]. Using the NotI-
microarray to study ccRCC samples, we have found 
that the PPM1M and PRICLE2 genes showed genetic 
and/or epigenetic changes [4]. It has been already 
shown that these genes play the role of TSG in cervical, 
ovarian and lung cancers [5–7]. 
Earlier we have shown that a reduction in the 
PPM1M and PRICKLE2 expression is typical for 
ccRCC; no promoter methylation was found for these 
genes, however [8]. It is known that these pro teins are 
ISSN 0233-7657 
Biopolymers and Cell. 2015. Vol. 31. N 1. P. 29–33
doi: http://dx.doi.org/10.7124/bc.0008C9 
© 2015 E. E. Rudenko et al.; Published by the Institute of Molecular Biology and Genetics, NAS of Ukraine on behalf of Biopolymers and Cell. 
    This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),
    which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited
30
E. E. Rudenko, Y. V. Lapska, G. V. Gerashchenko et al.
involved in the signalling pathways associated with 
carcinogenesis. In particular, PPM1M inhibits the IL-
1-NF-kappaB signalling pathway by selective de-
phosphorylating of IKKbeta [9]. PRICKLE2 is in-
volved in the WNT pathway of planar cell polarity 
determination (PCP), which regulated the polarity and 
movement of cells [10]. Therefore, there is a possibil-
ity that these two genes might be TSGs in ccRCC. 
In the present work we performed a detailed study of 
heterozygous deletions of the PPM1M and PRICKLE2 
genes in ccRCC and propose the new mechanism of 
deletion of these genes during carcinogenesis.
Materials and Methods
Tissue samples. Samples of surgically removed tu-
mors and surrounding tissues (considered as normal) 
were obtained from Kyiv National urology cen ter 
(Kyiv, Ukraine). All tissue samples were cha rac te-
rized according to the International System of Clini-
cal and morphological classifi cation of tumors (TNM) 
[11] and WHO classifi cation criteria [12]. The aver-
age age of patients was 48.59 (in the range of 30–68 
years). Normal tissues were obtained at a distance of 
at least 2 cm from the tumor and histologically con-
fi rmed as unchanged renal epithelial cells. Altogeth-
er, 18 samples of ccRCC were investigated, i.e. 12 
samples  at stage 1–2 and 6 samples at stage 3–4. 
Isolation of genomic DNA
Genomic DNA was isolated, using DNA purifi cation Kit 
(Fermentas, Lithuania), according to the manufacturer’s 
re-commendations. Quality of genomic DNA was as-
Table 1. Summary of analysis on gene copy number in ccRCC samples
Sample 
number Sex
Stage
of atypia Age
TNM
classifi cation
Copy number
of PPM1M 
Copy number
of PRICKLE2
  1 M 1 38 T2NxM0 0.979 [0.979; 0.981] 0.409 [0.408; 0.409]
  2 M 1 47 T2NxM0 2.761 [2.720; 2.801] 0.979 [0.979; 0.980]
  3 F 1 43 T3N0M0 0.677 [0.614;0.740] 1.287 [1.149;1.426]
  4 M 1 38 T2NxM0 1.212 [1.045; 1.377] 0.848 [0.781; 0.914]
  5 F 2 46 T2NxM0 0.759 [0.707;0.811] 0.809 [0.790;0.829]
  6 F 2 46 T2NxM0 0.933 [0.897;0.970] 1.009 [0.911;1.108]
  7 M 2 41 T3NxM0 0.706 [0.439; 0.973] 0.808 [0.729; 0.888]
  8 M 2 50 T2NxM0 0.973 [0.935; 1.011] 1.631 [1.575; 1. 686]
  9 F 2 45 T2NxM0 2.418 [1.947;2.889] 0,579 [0,528; 0,631] 
10 F 2 66 T3N0M0 0.507 [0.406: 0.608] 0.933 [0.879; 0.989]
11 M 2 68 T2NxM0 0.631 [0.591; 0.671] 0.470 [0.465;0.474]
12 M 2 38 T2NxM0 0.366 [0.318; 0.415] 0.431 [0.363; 0.501]
13 M 3 45 T2NxM0 0.847 [0.814; 0.880] 1.044 [0.850; 1.238]
14 M 3 67 T2NxM0 0.398 [0.374; 0.375] 1.025 [0.970; 1.080]
15 M 3 46 T2N0M0 0.705 [0.701; 0.708] 1.146 [0.989; 1.303]
16 F 4 61 T3N0M0 0.884 [0.690; 1.077] 1.429 [1.261; 1.597]
17 M 4 51 T3N0M0 1.675 [1.405; 1.945] 0.525 [0.509; 0.541]
18 M 4 62 T2NxM0 0.223 [0.213; 0.233] 0.368 [0.314; 0.422]
N o t e: Samples, which displayed ratio <0.35 and where gene was considered as homozygously deleted are marked bold italic. 
Samples, which displayed ratio <0.85 and ≥0.35 and where genes were considered as heterozygously deleted are shown in italic. 
Samples, which had ratio >0.85 and where genes showed unchanged copy number are marked regular text Samples, which displayed 
ratio >1.5 and where genes were amplifi ed marked bold.
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sessed by agarose gel electrophoresis; DNA concentra-
tion was measured, using a spectrophotometer Nano-
Drop ND-1000 (NanoDrop Technologies Inc., USA). 
The samples used for the Q-PCR reactions were of high 
molecular weight (OD 260/280 was in range 1.6–1.8). 
Analysis of gene copy number. The Q-PCR method 
and Bio-Rad iQ5 machine to quantify the number of 
gene copies were used. It was shown that this method 
is accurate enough to determine the number of allele 
copies. Each Q- PCR reaction contained 12.5 ul 
2xSYBR Green PCR Master Mix (Fermentas, Lithu-
ania), forward and reverse primers at a concentration 
of 400 nM, genomic DNA – 10 ng/ml, and sterile wa-
ter to make a fi nal volume 25 ul. Gene TBP was used 
as the reference [13]. The primer design was carried 
out, using a program Primer3 (http://frodo.wi.mit.edu/
primer3/) and In te grated DNA Technologies, http://
eu.idtdna.com/ analyzer/Applications/Oli goAnalyz-
er/). The follo wing primers were used (Invitrogen):
PPM1M_copy
LEFT PRIMER 5’-TCCGAATCCTGACAACTTC-3’
RIGHT PRIMER 5’- CCGAATGCTGGAACT CTA-3’
PRICKLE2_copy
LEFT PRIMER 5’-ATGTTTGCTCCTGGTTT CA-3’
RIGHT PRIMER 5’-ACTCAGACCCTCAGTTCAC-3’
TBP_copy
LEFT PRIMER 5’-ATAAAGCAGCAGCAGG GTTT-3’
RIGHT PRIMER 5’-AGTCAGTGTGGCAAACTTCG-3’
PCR was performed at the following conditions: 
denaturation at 95 C for 10 min, after this 35 cycles: 
denaturation at 95 C for 20 sec, annealing at 60 C 
for 20 sec, and elongation at 72 C for 40 sec.
Analysis of the number of copies of the PPM1M 
and PRICKLE2 genes was performed by 2-ΔΔCP 
relative quantitative analysis [14].
According to the histological analysis, the  contam-
ination of tumour samples by normal stroma lympho-
cytes could be up to 30–40 %. Therefore, the homozy-
gous deletions were considered when the calculated 
values were below 0.35; the heterozygous deletions 
were proposed if the calculated values were below 
0.85. The locus was considered as amplifi ed if the 
smallest of the range exceeded 1.5 [15]. 
Results and Discussion
An analysis of the gene copy number was perfor med 
for 18 samples of ccRCC and corresponding to them 
normal tissues (Table 1). 
The PPM1M gene was deleted in 55.6 % of cases 
(nine cases of heterozygous deletions and one ho-
mozygous deletion). Amplifi cation were observed in 
16.7 % (three samples), while 27.8 % cases were un-
changed (fi ve samples). Previously we have reported 
that the expression level of PPM1M altered in 50 % 
of cases in ccRCC tumors [8]. 
The product of PPM1M gene is a serine threonine 
phosphatase from  the PPM family (Mg2+- and Mn2+-
dependent). Phosphorylation is an important post-t-
ranslation modifi cation that regula tes many signaling 
systems and it is an effective way to control cellular 
internal and external signal responses [16]. Phos-
phatases together with kinases regulate phosphoryla-
tion and are involved in many physiological process-
es, such as cell migration, pro liferation, intracellular 
substrate localization, apo p tosis, differentiation, me-
tabolism, and immune sys tem response [17].
Phosphatases are also involved in the cell cycle 
regulation [18], therefore they are considered as sup-
pressors of tumor growth. Most probably, they sho-
uld be inactivated in the process of carcinogenesis. 
One of the functions of PPM1M is the inhibition of 
the IL-1-induced activation of NF-kappa-B. The IL-1 
is a cytokine that has different functions in control of 
infl ammation. [9].It is yet un known how PPM1M is 
involved in cancerogenesis [19].
Deletions in the PRICKLE gene were found in 50 % 
of samples (eight samples heterozygous deletions and 
one homozygous deletion). In 38.9 % (se ven samples) 
there were no changes in the copy num ber, while am-
plifi cation was observed in 11.1 % of cases (two sam-
ples). According to our previous da ta, the expression 
level of PRICKLE2 altered in 83 % of cases [8]. 
The PRICKLE2 protein is a member of WNT-cas-
cade that activates Fz-receptors on the cell surface. 
This pathway regulates the planar polarization of the 
cells that differ from the basal-apical polarization 
and is, actually, perpendicular to the latter [20]. Apart 
that the PRICKLE2 is attached to the inner surface 
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of the cell membrane by another protein – PCP- stra-
bismus, not much is known about its function [21].
Conclusions
Previously, we have shown that the expression of 
PRICKLE2 and PPM1M altered in ccRCC. In the 
present paper by the analysis of the gene copy num ber 
we have shown that homo- and heterozygous dele-
tions are the main reason of changes in the expres-
sion of these genes.
Funding
This work was partially supported by the project 
«Identifi cation of molecular genetic markers for 
diagnostics of malignant neoplasms of epithelial 
origin», state registration N 0110U004744.
REFERENCES
1. Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. 
Comparisons of outcome and prognostic features among 
histologic subtypes of renal cell carcinoma. Am J Surg 
Pathol. 2003;27(5):612–24.
2. Bhat S. Role of surgery in advanced/metastatic renal cell 
carcinoma. Indian J Urol. 2010;26(2):167–76.
3. Pavlovich CP, Schmidt LS, Phillips JL. The genetic basis of 
renal cell carcinoma. Urol Clin North Am. 2003;30(3):437–
54.
4. Dmitriev AA, Rudenko EE, Kudryavtseva AV, et al. Epige-
netic alterations of chromosome 3 revealed by NotI-mi-
croarrays in clear cell renal cell carcinoma. BioMed Re-
search International. 2014;2014:1–9.
5. Senchenko VN, Kisseljova NP, Ivanova TA, et al. Novel tu-
mor suppressor candidates on chromosome 3 revealed by 
NotI-microarrays in cervical cancer. Epigenetics. 2013;8 
(4):409–20.
6. Dmitriev AA, Kashuba VI, Haraldson K, et al. Genetic and 
epigenetic analysis of non-small cell lung cancer with NotI-
microarrays. Epigenetics. 2012;7(5):502–13.
7. Kashuba V, Dmitriev AA, Krasnov GS, et al. NotI microar-
rays: novel epigenetic markers for early detection and pro-
gnosis of high grade serous ovarian cancer. Int J Mol Sci. 
2012;13(10):13352–77.
8. Rudenko EE, Gerashchenko GV, Lapska YV, Vozianov SO, 
Zgonnyk YM, Kashuba VI. PPM1M and PRICKLE2 are po-
tential tumor suppressor genes in human clear-cell renal cell 
carcinoma. Biopolym Cell. 2014; 30(3):229–233.
9. Henmi T, Amano K, Nagaura Y, et al. A mechanism for the 
suppression of interleukin-1-induced nuclear factor kappaB 
activation by protein phosphatase 2Ceta-2. Biochem J. 2009; 
423(1):71–8.
10. Katoh M. WNT/PCP signaling pathway and human cancer 
(review). Oncol Rep. 2005;14(6):1583–8.
11. Speissel B, Beahrs OH, Hermanek P, Hutter RVP, Scheibe O. 
TNM atlas: illustrated guide to the TNM. pTNM classifi ca-
tion of malignant tumours. Berlin New York: Springer-Ver-
lag. 1989.
12. Travis WD, Coby TV, Corrin B, Shimosato Y, Brambilla E. 
World Health Organization International Histological Clas-
sifi cation of Tumours; Histological typing of lung and ple ural 
tumours. Berlin: Springer. 1999.
13. Jung M, Ramankulov A, Roigas J, et al. In search of suitable 
reference genes for gene expression studies of human renal 
cell carcinoma by real-time PCR. BMC Mol Biol. 2007; 
8:47.
14. Gerashchenko GV, Bogatyrova OO, Rudenko EE, et al. Ge-
netic and epigenetic changes of NKIRAS1 gene in human 
renal cell carcinomas. Exp Oncol. 2010;32(2):71–5.
15. Senchenko VN, Liu J, Loginov W, et al. Discovery of fre-
quent homozygous deletions in chromosome 3p21.3 LU CA 
and AP20 regions in renal, lung and breast carcinomas. On-
cogene. 2004;23(34):5719-28.
16. * Shakir SM, Bryant KM, Larabee JL. Regulatory interac-
tions of a virulence-associated serine. threonine phospha-
tase-kinase pair in Bacillus anthracis. J Bacteriol. 2010; 
192(2):400–9.
17. Shi Y. Serine/threonine phosphatases: mechanism thro ugh 
structure. Cell. 2009;139(3):468–84.
18. Dedinszki D, Kiss A, Márkász L, et al. Inhibition of protein 
phosphatase-1 and -2A decreases the chemosensitivity of leu-
kemic cells to chemotherapeutic drugs. Cell Signal. 2015; 
27(2):363–72.
19. Komaki K, Katsura K, Ohnishi M, et al. Molecular cloning 
of PP2Ceta, a novel member of the protein phosphatase 2C 
family. Biochim Biophys Acta. 2003;1630(2–3):130–7.
20. Fanto M, McNeill H. Planar polarity from fl ies to verte-
brates. J Cell Sci. 2004;117(Pt 4):527–33.
21. Bastock R. Strabismus is asymmetrically localised and binds to 
Prickle and Dishevelled during Drosophila planar polarity 
patterning. Development. 2003;130(13):3007–14.
33
Heterozygous deletions are main cause of expression alterations of PPM1M and PRICLE2 genes
Є. Є. Руденко, Ю. В. Лапська, Г. В. Геращенко,
Е. О. Стаховський, М. В. Вікарчук, В. І. Кашуба
Гетерозиготні делеції – основна причина змін
експресії генів PPM1M та PRICKLE2
у світлоклітинних карциномах нирки людини
Мета. Знайти механізм, відповідальний за зміну експресії ге-
нів PPM1M і PRICKLE2 у світлоклітинних карциномах нирки 
людини. Методи. Вивчення змін кількості ко пій генів було 
проведено за допомогою кількісної ПЛР (Q- ПЛР). Результа-
ти. Делеції гена PPM1M були знайдені у 55,6 % випадків, 
ампліфікації – у 16,7 %, а у 27,8 % зразків не було змін кіль-
кості копій гена. Ми виявили делеції гена PRICKLE2 у 50 % 
зразків, зміни не виявлено у 38,9 % зразків, а ампліфікації 
спостерігалися у 11,1 % випадків. Висновки. За допомогою 
аналізу кількості копій ге на ми показали, що гомо- та гетеро-
зиготні делеції є голов ною причиною зміни експресії генів 
PPM1M і PRICKLE2.
Ключові  слова: світлоклітинна карцинома нирки, ге-
те ро зиготні делеції, кількісна ПЛР, аналіз кількості ко-
пій гена.
Е. Е. Руденко, Ю. В. Лапская, А. В. Геращенко,
Э. А. Стаховский, М. В. Викарчук, В. И. Кашуба.
Гетерозиготные делеции являются основной причиной 
изменения экспресии генов PPM1M и PRICKLE2
в светлоклеточных карциномах почки человека
Цель. Найти механизм, ответственный за изменение эксп рес-
сии генов PPM1M и PRICKLE2 в светлоклеточных кар циномах 
почки человека. Методы. Изучение изменений ко ли чества ко-
пий проводили методом количественной ПЦР (Q-ПЦР). Ре-
зультаты. Делеции гена PPM1M были найде ны в 55,6 % случа-
ев, амплификации – в 16,7 %, а в 27,8 % образцов не было изме-
нений количества копий гена. Мы обнаружили делеции гена 
PRICKLE2 в 50 % образцов, в 38,9 % образцов изменений не 
обнаружено, амплификации наблюдались в 11,1 % случаев. 
Выводы. С помощью анализа количества копий гена мы пока-
зали, что гомо- и гетерозиготные делеции являются главной 
причиной изменения экспресии генов PPM1M и PRICKLE2.
Ключевые слова: светлоклеточная карцинома почки, ге те-
розиготные делеции, количественный ПЦР, анализ коли-
чества копий гена.
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